Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KAUSHALENDRA K SINGH

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1215029731
CMS profile
454828
Location
PALATKA, FL

General Payments · PY2018–2024

$2,718.42

  • Reported across 117 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$280.76

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $280.76 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $132.30 7
GlaxoSmithKline, LLC. $117.89 6
Inspire Medical Systems, Inc. $30.57 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $366.70 7
PY2019 $462.61 17
PY2020 $434.23 17
PY2021 $311.85 14
PY2022 $299.85 17
PY2023 $562.42 30
PY2024 $280.76 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $18.72 01/24/2024 Food and Beverage Undisputed 01/23/2026 1105205855 CMS
AstraZeneca Pharmaceuticals LP $25.29 01/24/2024 Food and Beverage Undisputed 01/23/2026 1105861640 CMS
AstraZeneca Pharmaceuticals LP $17.36 02/26/2024 Food and Beverage Undisputed 01/23/2026 1104500096 CMS
AstraZeneca Pharmaceuticals LP $23.28 03/18/2024 Food and Beverage Undisputed 01/23/2026 1105666742 CMS
AstraZeneca Pharmaceuticals LP $17.43 04/22/2024 Food and Beverage Undisputed 01/23/2026 1104716089 CMS
AstraZeneca Pharmaceuticals LP $16.62 05/20/2024 Food and Beverage Undisputed 01/23/2026 1104246589 CMS
AstraZeneca Pharmaceuticals LP $13.60 06/17/2024 Food and Beverage Undisputed 01/23/2026 1105702740 CMS
GlaxoSmithKline, LLC. $22.20 01/10/2024 Food and Beverage Undisputed 01/23/2026 1116584377 CMS
GlaxoSmithKline, LLC. $18.81 02/23/2024 Food and Beverage Undisputed 01/23/2026 1116667988 CMS
GlaxoSmithKline, LLC. $18.99 02/28/2024 Food and Beverage Undisputed 01/23/2026 1115981807 CMS
GlaxoSmithKline, LLC. $20.65 04/04/2024 Food and Beverage Undisputed 01/23/2026 1116461504 CMS
GlaxoSmithKline, LLC. $21.78 04/17/2024 Food and Beverage Undisputed 01/23/2026 1116292587 CMS
GlaxoSmithKline, LLC. $15.46 05/22/2024 Food and Beverage Undisputed 01/23/2026 1115982587 CMS
Inspire Medical Systems, Inc. $14.57 02/29/2024 Food and Beverage Undisputed 01/23/2026 1148112037 CMS
Inspire Medical Systems, Inc. $16.00 03/06/2024 Food and Beverage Undisputed 01/23/2026 1148112041 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.